Straumann Holding AG Cash on Hand 2012-2025 | SAUHY
Straumann Holding AG cash on hand from 2012 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Straumann Holding AG cash on hand for the quarter ending December 31, 2025 was $0.618B, a 15.64% decline year-over-year.
- Straumann Holding AG cash on hand for 2025 was $0.618B, a 17.01% increase from 2024.
- Straumann Holding AG cash on hand for 2024 was $0.528B, a 13.07% increase from 2023.
- Straumann Holding AG cash on hand for 2023 was $0.467B, a 36.24% decline from 2022.
|
Straumann Holding AG Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $618 |
| 2024 | $528 |
| 2023 | $467 |
| 2022 | $732 |
| 2021 | $966 |
| 2020 | $675 |
| 2019 | $264 |
| 2018 | $286 |
| 2017 | $289 |
| 2016 | $168 |
| 2015 | $332 |
| 2014 | $506 |
| 2013 | $416 |
| 2012 | $150 |
| 2011 | $428 |
|
Straumann Holding AG Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-12-31 | $618 |
| 2024-12-31 | $528 |
| 2024-06-30 | $380 |
| 2023-12-31 | $467 |
| 2022-12-31 | $732 |
| 2021-12-31 | $966 |
| 2021-06-30 | $796 |
| 2020-12-31 | $675 |
| 2020-06-30 | $395 |
| 2019-12-31 | $264 |
| 2018-12-31 | $286 |
| 2017-12-31 | $289 |
| 2017-06-30 | $143 |
| 2016-12-31 | $168 |
| 2016-06-30 | $315 |
| 2015-12-31 | $332 |
| 2014-12-31 | $506 |
| 2013-12-31 | $416 |
| 2013-06-30 | $344 |
| 2012-12-31 | $150 |
| 2012-06-30 | $126 |
| 2011-12-31 | $428 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $16.902B | $3.144B |
| The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |